Abstract
Purpose
This study seeks to update current epidemiology of Hirschsprung disease (HD) in California.
Methods
Using data from the California Office of Statewide Health Planning and Development Linked Birth (1995–2012) and Patient Discharge Databases (1995–2013), patients from either dataset with an ICD-9 diagnosis code of HD (751.3) or procedure code of Soave (48.41), Duhamel (48.65), or Swenson/other pull-through (48.49) were included. Patients > age 18 during their first admission were excluded.
Results
Of 9.3 million births, 2,464 patients were identified. Incidence was 2.2 cases/10,000 live births, with rates peaking at 2.9/10,000 births in 2002. Incidence was highest among African American (4.1/10,000) and Asian/Pacific Islander (2.5/10,000) births. Most were male (n = 1652, 67.1%). Sixty patients (2.4%) had Down syndrome. The median gestational age at birth was 38 weeks 6 days (interquartile range [IQR] 37 weeks 1 day–40 weeks 1 day). Mortality during the first year of life was 1.7%. Median age at death was 14.5 days (IQR 0–113 days).
Conclusion
This is one of the largest population-based studies of HD. In California, the incidence of HD is stable, risk is highest among African American children, and the mortality rate is < 2%.
Similar content being viewed by others
References
Torfs CP (1996) The epidemiology of Hirschsprung disease in a large multiracial population. Teratology 53:93
Goldberg E (1984) An epidemiological study of Hirschsprung’s disease. Int J Epidemiol 13:479–485
Downey EC, Hughes E, Putnam AR, Baskin HJ, Rollins MD (2015) Hirschsprung disease in the premature newborn: a population-based study and 40-year single center experience. J Pediatr Surg 50(1):123–125
Meza-Valencia BE, de Lorimier AJ, Person DA (2005) Hirschsprung disease in the US associated Pacific Islands: more common than expected. Hawaii Med J 64(4):96–98 (100–1)
Spouge D, Baire PA (1985) Hirschsprung disease in a large birth cohort. Teratology 32(2):171–177
Nasr A, Sullivan KJ, Chan EW, Wong CA, Benchimol EI (2017) Validation of algorithms to determine incidence of Hirschsprung disease in Ontario, Canada: a population-based study using health administrative data. Clin Epidemiol 9:579–590
Best KE, Addor MC, Arriola L, Balku E, Barisic I, Bianchi F et al (2014) Hirschsprung’s disease prevalence in Europe: a register based study. Birth Defects Res (Part A) 100:695–702
Bradnock TJ, Knight M, Kenny S, Nair M, Walker GM, British Association of Paediatric Surgeons Congenital Anomalies Surveillance System (2017) Hirschsprung’s disease in the UK and Ireland: incidence and anomalies. Arch Dis Child 102(8):722–727
Best KE, Glinianaia SV, Bythell M, Rankin J (2012) Hirschsprung’s disease in the North of England: prevalence, associated anomalies, and survival. Birth Defects Res A Clin Mol Teratol 94(6):477–480
Russell MB, Russell CA, Niebuhr E (1994) An epidemiological study of Hirschsprung’s disease and additional anomalies. Acta Paediatr 83:68–71
Taguchi T, Obata S, Ieiri S (2017) Current status of Hirschsprung’s disease: based on a nationwide survey of Japan. Pediatr Surg Int 33:497–504
Ikeda K, Goto S (1984) Diagnosis and treatment of Hirschsprung’s disease in Japan. An analysis of 1628 patients. Ann Surg 199(4):400–405
Chia ST, Chen SC, Lu CL, Sheu SM, Kuo HC (2016) Epidemiology of Hirschsprung’s disease in Taiwanese children: a 13-year nationwide population-based study. Pediatr Neonatol 57(3):201–206
Rajab A, Freeman NV, Patton MA (1997) Hirschsprung’s disease in Oman. J Pediatr Surg 32(5):724–727
Ieiri S, Higashi M, Teshiba R, Saeki I, Esumi G, Akiyoshi J et al (2009) Clinical features of Hirschsprung’s disease associated with Down syndrome: a 30-year retrospective nationwide survey in Japan. J Pediatr Surg 44(12):2347–2351
Menezes M, Puri P (2005) Long-term clinical outcome in patients with Hirschsprung’s disease and associated Down’s syndrome. J Pediatr Surg 40(5):810–812
Lof Granstrom A, Wester T (2017) Mortality in Swedish patients with Hirschsprung disease. Pediatr Surg Int 33(11):1177–1181
Funding
This study was not funded.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None of the authors have any conflicts of interest to declare.
Ethical approval
All studies involving human participants were in accordance with the ethical standards of the institutional and state research committees (UC Davis Institutional Review Board and the California Committee for the Protection of Human Subjects) and with the 1964 Helsinki declaration and its later amendments.
Informed consent
Informed consent was not obtained as this was a database study and consent was not able to be obtained and data were deidentified; this was found to be acceptable per the institutional research committees listed above.
Rights and permissions
About this article
Cite this article
Anderson, J.E., Vanover, M.A., Saadai, P. et al. Epidemiology of Hirschsprung disease in California from 1995 to 2013. Pediatr Surg Int 34, 1299–1303 (2018). https://doi.org/10.1007/s00383-018-4363-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-018-4363-9